Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
Identificadores
Identificadores
Fecha de publicación
2011Título de revista
LEUKEMIA & LYMPHOMA
Tipo de contenido
Artigo